๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A comparative randomized trial of vinca alkaloids in patients with metastatic breast carcinoma

โœ Scribed by Jonathan C. Yau; Ywee-Yong Yap; Aman U. Buzdar; Gabriel N. Hortobagyi; Gerald P. Bodey; George R. Blumenschein


Publisher
John Wiley and Sons
Year
1985
Tongue
English
Weight
377 KB
Volume
55
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Prospective randomized reappraisal of 5-
โœ Cary A. Presant; Alex E. Denes; Charlene Liu; Alfred A. Bartolucci; The Southeas ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 488 KB ๐Ÿ‘ 2 views

In order to redefine the effectiveness of 5-fluorouracil (5-FU) as palliative therapy in patients with metastatic colorectal carcinoma, and to compare the effectiveness of 6-thioguanine (6-TG) with that of 5-FU, we studied 176 patients with metastatic colorectal carcinoma in a randomized prospective

Predictors of skeletal complications in
โœ Susan M. Domchek; Jerry Younger; Dianne M. Finkelstein; Michael V. Seiden ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 83 KB ๐Ÿ‘ 1 views

## Background: The high rate of incidence of skeletal complications in women with metastatic breast carcinoma appears to contribute significantly to their morbidity. although recent trials have demonstrated the efficacy of bisphosphonates in preventing skeletal complications in selected patients, t

A randomized trial of tamoxifen alone or
โœ James N. Ingle; Vera J. Suman; Carl G. Kardinal; James E. Krook; James A. Mailli ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 110 KB ๐Ÿ‘ 2 views

## BACKGROUND. Tamoxifen (TAM) is generally considered the hormonal agent of choice for postmenopausal women with hormone receptor positive breast carcinoma. The somatostatin analogues, including octreotide, have demonstrated inhibition of breast carcinoma cell lines and multiple endocrinologic act